Sartorius Stedim Biotech S.A. 56S1.F Stock
Sartorius Stedim Biotech S.A. Price Chart
Sartorius Stedim Biotech S.A. 56S1.F Financial and Trading Overview
| Sartorius Stedim Biotech S.A. stock price | 256.4 EUR |
| Previous Close | 275.9 EUR |
| Open | 275.5 EUR |
| Bid | 280.6 EUR x 20000 |
| Ask | 281.1 EUR x 20000 |
| Day's Range | 275.5 - 275.5 EUR |
| 52 Week Range | 239 - 399.3 EUR |
| Volume | 32 EUR |
| Avg. Volume | 22 EUR |
| Market Cap | 26.05B EUR |
| Beta (5Y Monthly) | 0.442528 |
| PE Ratio (TTM) | 36.29776 |
| EPS (TTM) | 3.36 EUR |
| Forward Dividend & Yield | 1.44 (0.54%) |
| Ex-Dividend Date | March 30, 2023 |
| 1y Target Est | N/A |
56S1.F Valuation Measures
| Enterprise Value | 26.17B EUR |
| Trailing P/E | 36.29776 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.7613297 |
| Price/Book (mrq) | 10.4518385 |
| Enterprise Value/Revenue | 7.796 |
| Enterprise Value/EBITDA | 22.571 |
Trading Information
Sartorius Stedim Biotech S.A. Stock Price History
| Beta (5Y Monthly) | 0.442528 |
| 52-Week Change | -4.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 399.3 EUR |
| 52 Week Low | 239 EUR |
| 50-Day Moving Average | 261.95 EUR |
| 200-Day Moving Average | 309.68 EUR |
56S1.F Share Statistics
| Avg. Volume (3 month) | 22 EUR |
| Avg. Daily Volume (10-Days) | 23 EUR |
| Shares Outstanding | 92.16M |
| Float | 24.22M |
| Short Ratio | N/A |
| % Held by Insiders | 73.81% |
| % Held by Institutions | 12.98% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1849 |
| Last Split Factor | 6:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 21.36% |
| Operating Margin (ttm) | 30.05% |
| Gross Margin | 52.27% |
| EBITDA Margin | 34.54% |
Management Effectiveness
| Return on Assets (ttm) | 13.62% |
| Return on Equity (ttm) | 32.37% |
Income Statement
| Revenue (ttm) | 3.36B EUR |
| Revenue Per Share (ttm) | 36.46 EUR |
| Quarterly Revenue Growth (yoy) | -15.80% |
| Gross Profit (ttm) | 1.83B EUR |
| EBITDA | 1.16B EUR |
| Net Income Avi to Common (ttm) | 717M EUR |
| Diluted EPS (ttm) | 7.59 |
| Quarterly Earnings Growth (yoy) | -58.89% |
Balance Sheet
| Total Cash (mrq) | 94M EUR |
| Total Cash Per Share (mrq) | 1.02 EUR |
| Total Debt (mrq) | 1.31B EUR |
| Total Debt/Equity (mrq) | 53.25 EUR |
| Current Ratio (mrq) | 1.43 |
| Book Value Per Share (mrq) | 26.359 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 606.2M EUR |
| Levered Free Cash Flow (ttm) | 63.14M EUR |
Profile of Sartorius Stedim Biotech S.A.
| Country | Germany |
| State | N/A |
| City | Aubagne |
| Address | Zone Industrielle Les Paluds |
| ZIP | 13781 |
| Phone | 33 4 42 84 56 00 |
| Website | https://www.sartorius.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 11934 |
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; batch and intensified chromatography systems for smaller molecules applications, such as oligonucleotides, peptides, and insulin; and recombinant albumin based solutions. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. It serves manufacturers of medications, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Q&A For Sartorius Stedim Biotech S.A. Stock
What is a current 56S1.F stock price?
Sartorius Stedim Biotech S.A. 56S1.F stock price today per share is 256.4 EUR.
How to purchase Sartorius Stedim Biotech S.A. stock?
You can buy 56S1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sartorius Stedim Biotech S.A.?
The stock symbol or ticker of Sartorius Stedim Biotech S.A. is 56S1.F.
Which industry does the Sartorius Stedim Biotech S.A. company belong to?
The Sartorius Stedim Biotech S.A. industry is Medical Instruments & Supplies.
How many shares does Sartorius Stedim Biotech S.A. have in circulation?
The max supply of Sartorius Stedim Biotech S.A. shares is 97.31M.
What is Sartorius Stedim Biotech S.A. Price to Earnings Ratio (PE Ratio)?
Sartorius Stedim Biotech S.A. PE Ratio is 76.30952500 now.
What was Sartorius Stedim Biotech S.A. earnings per share over the trailing 12 months (TTM)?
Sartorius Stedim Biotech S.A. EPS is 3.36 EUR over the trailing 12 months.
Which sector does the Sartorius Stedim Biotech S.A. company belong to?
The Sartorius Stedim Biotech S.A. sector is Healthcare.